{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:33Z","timestamp":1793729433598,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.humpath.2025.105904","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T06:47:51Z","timestamp":1754549271000},"page":"105904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinoma"],"prefix":"10.1016","volume":"163","author":[{"given":"William","family":"Mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxuan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Czerniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2182-3287","authenticated-orcid":false,"given":"Charles C.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105904_bib1","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2025.105904_bib2","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2025.105904_bib3","series-title":"Urinary and male genital tumours","author":"Board","year":"2022"},{"key":"10.1016\/j.humpath.2025.105904_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12885-021-08418-y","article-title":"Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca cancer registry associated to survival","volume":"21","author":"Ripoll","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2025.105904_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3233\/BLC-189035","article-title":"Financial toxicity of having bladder cancer","volume":"4","author":"Messing","year":"2018","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.humpath.2025.105904_bib6","series-title":"Histological typing of urinary bladder tumours","author":"Mostofi","year":"1973"},{"key":"10.1016\/j.humpath.2025.105904_bib7","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/international society of urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder consensus conference committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105904_bib8","series-title":"Pathology and genetics of tumours of the urinary system and Male genital organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.humpath.2025.105904_bib9","series-title":"WHO classification of tumours of the urinary system and Male genital organs","author":"Moch","year":"2016"},{"key":"10.1016\/j.humpath.2025.105904_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euf.2018.01.003","article-title":"Grading of urothelial carcinoma and the new \"World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016\"","volume":"5","author":"Comp\u00e9rat","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.humpath.2025.105904_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.eururo.2017.04.015","volume":"72","author":"Soukup","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2025.105904_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.eururo.2009.03.052","article-title":"Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications","volume":"57","author":"May","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2025.105904_bib13","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8","article-title":"Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.105904_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2015.09.007","article-title":"Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder","volume":"47","author":"Reis","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105904_bib15","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.juro.2013.11.056","article-title":"Mixed high and low grade bladder tumors--are they clinically high or low grade?","volume":"191","author":"Gofrit","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2025.105904_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urology.2017.03.034","article-title":"European Association of urology and American urological association\/society of urologic oncology guidelines on risk categories for non-muscle-invasive bladder cancer may lead to overtreatment for low-grade Ta bladder tumors","volume":"105","author":"Klaassen","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2025.105904_bib17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00345-015-1548-x","article-title":"Impact of 2004 ISUP\/WHO classification on bladder cancer grading","volume":"33","author":"Lokeshwar","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2025.105904_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2021.04.002","article-title":"Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall","volume":"113","author":"Matoso","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105904_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/10668969241246492","article-title":"Outcome analysis of a series of mixed-grade, non-muscle invasive, papillary carcinomas of the bladder","volume":"33","author":"Chambers","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105904_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/bju.16686","article-title":"Long-term multicentre analysis of robot-assisted radical cystectomy for non-muscle-invasive bladder cancer","author":"Tillu","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2025.105904_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4274\/MMJ.galenos.2021.48447","article-title":"The clinical impact of tumor grade heterogeneity in non-muscle-invasive urothelial carcinoma of the bladder","volume":"36","author":"Culpan","year":"2021","journal-title":"Medeni Med J"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725001911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725001911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:20:11Z","timestamp":1758986411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":21,"alternative-id":["S0046817725001911"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105904","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105904"}}